International comparison of the factors influencing reimbursement of targeted anti-cancer drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
International comparison of the factors influencing reimbursement of targeted anti-cancer drugs ; volume:14 ; number:1 ; day:29 ; month:11 ; year:2014 ; pages:1-10 ; date:12.2014
BMC health services research ; 14, Heft 1 (29.11.2014), 1-10, 12.2014
- Creator
-
Lim, Carol Sunghye
- Contributor
-
Lee, Yun-Gyoo
Koh, Youngil
Heo, Dae Seog
SpringerLink (Online service)
- DOI
-
10.1186/s12913-014-0595-0
- URN
-
urn:nbn:de:1111-201607222039
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lim, Carol Sunghye
- Lee, Yun-Gyoo
- Koh, Youngil
- Heo, Dae Seog
- SpringerLink (Online service)
Other Objects (12)
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
Deposit Insurance: Reimbursement of Depositors
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
Molecular targeted therapy for anticancer treatment
Clinical development of targeted and immune based anti-cancer therapies
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
The prince and the pauper. A tale of anticancer targeted agents
Metal-peptide bioconjugates for targeted anti-cancer therapy
MISSION FIELD REIMBURSEMENT FILE
Medical malpractice: the role of liability and reimbursement
Reimbursement of Medicine Outlays: An Optimal Insurance Approach
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
Deposit Insurance: Reimbursement of Depositors
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
Molecular targeted therapy for anticancer treatment
Clinical development of targeted and immune based anti-cancer therapies
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
The prince and the pauper. A tale of anticancer targeted agents
Metal-peptide bioconjugates for targeted anti-cancer therapy
MISSION FIELD REIMBURSEMENT FILE
Medical malpractice: the role of liability and reimbursement
Reimbursement of Medicine Outlays: An Optimal Insurance Approach
Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective
Deposit Insurance: Reimbursement of Depositors
Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics
Molecular targeted therapy for anticancer treatment
Clinical development of targeted and immune based anti-cancer therapies
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
The prince and the pauper. A tale of anticancer targeted agents
Metal-peptide bioconjugates for targeted anti-cancer therapy
MISSION FIELD REIMBURSEMENT FILE
Medical malpractice: the role of liability and reimbursement